Interventional procedures play an integral role in managing traumatic pediatric injuries nonoperatively, though specific guidelines for the use of endovascular interventions in this setting have not been fully defined prior to these latest recommendations.

The issue at the center of this recall, which includes both the HeartMate II and HeartMate 3 LVAD, is the gradual buildup of biological materials. This can impact the device's performance, creating a heightened risk of injury or death. 

Lawmakers held a hearing on this topic April 11, titled “Bolstering Chronic Care through Medicare Physician Payment," featuring testimony multiple medical specialty societies. 

There is a rapidly growing shortage in general cardiologists and for positions in rural areas, numerous healthcare system recruiters set up at the ACC reported.

Both bills would have granted expanded authority to APRNs but were vetoed by governors amid fierce physician lobbying. 

CMS has issued a proposed rule that would result in a net increase of 2.6% to the Medicare inpatient prospective payment system rate for fiscal year 2025, a raise that hospital trade groups say doesn’t go far enough.

A recent investigation from KFF Health News about payments to members of an FDA panel evaluating an Abbott Laboratories cardiac device is raising eyebrows.

The Private Equity Stakeholder Project’s new State Risk Index is calculated based on 16 unique indicators.